Clinical Trials Browser

Phase EARLY_PHASE1 × Thyroid Neoplasms × durvalumab × Clear all

NCT03215095 2025-07-17

RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers

Phase EARLY_PHASE1 Active not recruiting

11 enrolled 6 charts

Thyroid Neoplasms